The Clorox Company
89.62USD
-1.9800 (-2.16%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.11▼ | $1.29 | 1 | 10 |
| Next quarter | $1.37▼ | $1.43 | 1 | 10 |
| Current year | $5.81▼ | $6.31 | 3 | 13 |
| Next year | $6.29▼ | $6.84 | 1 | 8 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.65 | $1.66 | +0.01 (+0.9%) |
| 2026-03-31 | $1.54 | $1.64 | +0.10 (+6.2%) |
| 2025-12-31 | $1.43 | $1.39 | -0.04 (-3.0%) |
| 2025-09-30 | $0.78 | $0.85 | +0.07 (+9.2%) |
344 ratings from 29 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $100 $105 | Aug 4, 2026 |
| JP Morgan | Maintained | Underweight | $92 $95 | Aug 4, 2026 |
| Citigroup | Maintained | Neutral | $97 $100 | Aug 4, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $95 $102 | Aug 4, 2026 |
| Evercore ISI Group | Maintained | Underperform | $98 $99 | Aug 4, 2026 |
| Jefferies | Downgraded from Buy | Hold | $125 $98 | Jul 28, 2026 |
| Evercore ISI Group | Maintained | Underperform | $110 $98 | Jul 23, 2026 |
| Barclays | Maintained | Underweight | $85 $86 | Jul 21, 2026 |
| BNP Paribas | Maintained | Neutral | $97 $95 | Jul 20, 2026 |
| JP Morgan | Maintained | Underweight | $95 $92 | Jul 16, 2026 |
| UBS | Maintained | Neutral | $96 $100 | Jul 16, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $100 $95 | May 18, 2026 |
| Barclays | Maintained | Underweight | $102 $85 | May 4, 2026 |
| UBS | Maintained | Neutral | $110 $96 | May 1, 2026 |
| Citigroup | Maintained | Neutral | $110 $97 | May 1, 2026 |
| JP Morgan | Maintained | Underweight | $99 $95 | May 1, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $110 $100 | May 1, 2026 |
| Evercore ISI Group | Maintained | Underperform | $115 $110 | May 1, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $136 $110 | Apr 23, 2026 |
| Jefferies | Maintained | Buy | $151 $139 | Apr 21, 2026 |
| JP Morgan | Downgraded from Neutral | Underweight | $117 $99 | Apr 17, 2026 |
| Citigroup | Maintained | Neutral | $115 $110 | Apr 15, 2026 |
| Barclays | Maintained | Underweight | $109 $102 | Apr 15, 2026 |
| Barclays | Maintained | Underweight | $109 $102 | Apr 14, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $125 $110 | Apr 8, 2026 |
52 filings from 14 insiders · 0 buy / 0 sell over 6m
Officers and directors of CLX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HILT ANGELA CHRISTINEOfficer | Grant | 26.3k | $94.97 | $2.50M | Jun 17, 2026 |
| HYDER CHRIS TChief Operating Officer | Grant | 42.1k | $94.97 | $4.00M | Jun 17, 2026 |
| BELLET LUCChief Financial Officer | Grant | 42.1k | $94.97 | $4.00M | Jun 17, 2026 |
| MARRINER KIRSTENOfficer | Grant | 26.3k | $94.97 | $2.50M | Jun 17, 2026 |
| BREBER PIERRE R.Director | Buyindirect | 5.0k | $85.82 | $429k | May 5, 2026 |
| BREBER PIERRE R.Director | Buyindirect | 4.0k | $104.13 | $417k | Nov 21, 2025 |
| HILT ANGELA CHRISTINEOfficer | Grant | 8.7k | $122.25 | $1.06M | Oct 3, 2025 |
| PECK LAURENE EOfficer | Grant | 1.4k | $122.25 | $173k | Oct 3, 2025 |
| HYDER CHRIS TOfficer | Grant | 6.8k | $122.25 | $833k | Oct 3, 2025 |
| BELLET LUCChief Financial Officer | Grant | 2.6k | $122.25 | $316k | Oct 3, 2025 |
| RENDLE LINDA JChief Executive Officer | Grant | 43.4k | $122.25 | $5.30M | Oct 3, 2025 |
| GRIER STACEYOfficer | Grant | 9.9k | $122.25 | $1.21M | Oct 3, 2025 |
| REYNOLDS ERIC HChief Operating Officer | Grant | 15.5k | $122.25 | $1.89M | Oct 3, 2025 |
| MARRINER KIRSTENOfficer | Grant | 9.3k | $122.25 | $1.14M | Oct 3, 2025 |
| HILT ANGELA CHRISTINEOfficer | Grant | 7.0k | $124.85 | $880k | Sep 16, 2025 |
| PECK LAURENE EOfficer | Grant | 1.4k | $124.85 | $180k | Sep 16, 2025 |
| HYDER CHRIS TOfficer | Grant | 7.2k | $124.85 | $900k | Sep 16, 2025 |
| BELLET LUCChief Financial Officer | Grant | 7.4k | $124.85 | $920k | Sep 16, 2025 |
| RENDLE LINDA JChief Executive Officer | Grant | 34.3k | $124.85 | $4.28M | Sep 16, 2025 |
| GRIER STACEYOfficer | Grant | 3.4k | $124.85 | $420k | Sep 16, 2025 |
No analyst notes on CLX yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 14 | 2 | 2 | Hold3.26 |
| 1 mo ago | 0 | 1 | 14 | 2 | 2 | Hold3.26 |
| 2 mo ago | 0 | 1 | 14 | 2 | 2 | Hold3.26 |
| 3 mo ago | 0 | 2 | 13 | 2 | 2 | Hold3.21 |